NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Dahabreh IJ, Moorthy D, Lamont JL, et al. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. (Comparative Effectiveness Reviews, No. 125.)
Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment [Internet].
Show details< PrevNext >
- Detailed Assessment of the Strength of Evidence - Testing of CYP2C19 Variants an...Detailed Assessment of the Strength of Evidence - Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
- MRSA Full-Text Screening Form - Screening for Methicillin-Resistant Staphylococc...MRSA Full-Text Screening Form - Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Risk-of-Bias Tables - Otitis Media With Effusion: Comparative Effectiveness of T...Risk-of-Bias Tables - Otitis Media With Effusion: Comparative Effectiveness of Treatments
- Appendix Tables for Key Question 1 - Testing of CYP2C19 Variants and Platelet Re...Appendix Tables for Key Question 1 - Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
- Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Meno...Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Menopausal Symptoms: Comparative Effectiveness of Therapies
Your browsing activity is empty.
Activity recording is turned off.
See more...